Another downstream component of PI3K signaling pathways in B cells, Btk, promotes the development of lupus in mouse models (40–44) and is being targeted in several clinical trials in SLE (www.clinicaltrials.gov). This evidence concerns the gene BTK and systemic lupus erythematosus.